07Aug/13

First Patient Treated with Civacir® after Hepatitis C Induced Liver … – MarketWatch (press release)

First Patient Treated with Civacir® after Hepatitis C Induced Liver
MarketWatch (press release)
Civacir, a 10 % hepatitis C hyperimmune globulin developed and produced at Biotest Pharmaceuticals Corporation, a wholly owned subsidiary of Biotest AG, is being used in a clinical trial in North America in patients undergoing liver transplantation as
Biotest commences phase III trial of hepatitis C therapyZenopa

all 2 news articles »

07Aug/13

First Patient Treated with Civacir® after Hepatitis C Induced Liver … – PR Newswire (press release)

First Patient Treated with Civacir® after Hepatitis C Induced Liver
PR Newswire (press release)
After treatment with virostatics over several weeks, the first patient underwent liver transplantation and subsequently was treated with the Civacir in the Phase III clinical trial. Civacir, a 10 % hepatitis C hyperimmune globulin developed and
Biotest commences phase III trial of hepatitis C therapyZenopa

all 2 news articles »

07Aug/13

Seanad being recalled to discuss organ donor legislation – RTE.ie


Irish Independent

Seanad being recalled to discuss organ donor legislation
RTE.ie
Cathaoirleach of the Seanad Paddy Burke has confirmed he will recall the Upper House from its summer break to discuss organ donor legislation. The recall was forced by Fianna Fáil Senator Mark Daly who got 20 senators to back his call to discuss an EU 
Pundit Brolly hits out over Seanad recall in organ donor rowIrish Independent
Seanad likely to be recalled to discuss law on organ donationIrish Times
Galway Senator signs consent to recall SeanadGalway Bay FM

all 5 news articles »